Detalles de la búsqueda
1.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Lancet Oncol
; 15(7): 738-46, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24836273
2.
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Eur Urol
; 73(3): 427-435, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705540
3.
A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.
Eur Urol
; 63(2): 189-97, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23000088
Resultados
1 -
3
de 3
1
Próxima >
>>